RECRUITINGINTERVENTIONAL
HIV Treatment Adherence Dose Determination Trial
DOSE DETERMINATION TRIAL: The Start/Persist Studies
About This Trial
The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost to guide health policy and implementation of behavioral interventions designed to improve durable viral suppression.
Who May Be Eligible (Plain English)
Who May Qualify:
- Confirmed HIV positive
- Confirmed prescribed antiretroviral therapy
- Confirmed non-adherent to anti-retroviral therapy
Who Should NOT Join This Trial:
- Does not have access to a phone
- Does not have access to the internet
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Confirmed HIV positive
* Confirmed prescribed antiretroviral therapy
* Confirmed non-adherent to anti-retroviral therapy
Exclusion Criteria:
* Does not have access to a phone
* Does not have access to the internet
Treatments Being Tested
BEHAVIORAL
Behavioral Self-Regulation Adherence Counseling
Telephone-delivered counseling to focus on cognitive-behavioral skills to improve HIV treatment adherence.
Locations (2)
University of Connecticut
Storrs, Connecticut, United States
University of Connecticut Field Site
Atlanta, Georgia, United States